Lipoid pneumonia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 25: Line 25:
*** Transthoracic fine-needle aspiration cytology
*** Transthoracic fine-needle aspiration cytology
*** Biopsy from lesion
*** Biopsy from lesion
** Sputum examination has questionable reliability because lipid-laden macrophages in sputum have been demonstrated in the absence of lipoid pneumonia.
** Sputum examination has questionable reliability because lipid-laden macrophages in sputum have been demonstrated in the absence of lipoid pneumonia.
** BAL is widely available and the choice of specimen taking today.
** BAL is widely available and the choice of specimen taking today.
Line 33: Line 32:
**# compatible radiological findings
**# compatible radiological findings
**# presence of intra-alveolar lipids and/or lipid-laden macrophages
**# presence of intra-alveolar lipids and/or lipid-laden macrophages
{|
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"

Revision as of 13:45, 15 October 2019

Lipoid pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lipoid pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lipoid pneumonia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lipoid pneumonia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lipoid pneumonia differential diagnosis

CDC on Lipoid pneumonia differential diagnosis

Lipoid pneumonia differential diagnosis in the news

Blogs on Lipoid pneumonia differential diagnosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Lipoid pneumonia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

OR

[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].

Differentiating lipoid pneumonia from other Diseases

  • Lipod pneumonia must be differentiated from other diseases that cause Cough with basilar infiltrates, such as bacterial pneumonia, viral pneumonia, congestive heart failure, pulmonary fibrosis, and aspiration pneumonia.[1]
  • Differentiating exogenous lipoid pneumonia from other diseases on the basis of radiologic features and specimen histologic features:[2]
    • Exogenous lipoid pneumonia is usually misdiagnosed as community-acquired pneumonia.
    • It is considered usually as the initial diagnosis that does not lead to appropriate therapy.
    • In patients at risk of aspiration early CT scan is very useful for further diagnosis of lipoid pneumonia.
    • Diagnosis is confirmed by detecting intra-alveolar lipid and lipid-laden macrophages.
    • specimens could be brought by:
      • BAL (Broncho Alveolar Lavage)
      • Transthoracic fine-needle aspiration cytology
      • Biopsy from lesion
    • Sputum examination has questionable reliability because lipid-laden macrophages in sputum have been demonstrated in the absence of lipoid pneumonia.
    • BAL is widely available and the choice of specimen taking today.
    • Frozen samples must be stained in order to determine the type of oil.
    • Since lipid-laden pneumonia is is very sensitive but may not be very specific, the diagnosis of exogenous lipoid pneumonia is based on the triad of:
      1. History of mineral oil ingestion or vaping
      2. compatible radiological findings
      3. presence of intra-alveolar lipids and/or lipid-laden macrophages
Diseases Diagnostic tests Physical Examination Symptoms Past medical history Other Findings
CT scan and MRI EKG Chest X-ray Tachypnea Tachycardia Fever Chest Pain Hemoptysis Dyspnea on Exertion Wheezing Chest Tenderness Nasalopharyngeal Ulceration Carotid Bruit
Pulmonary embolism
  • On CT angiography:
    • Intra-luminal filling defect
  • On MRI:
    • Narrowing of involved vessel
    • No contrast seen distal to obstruction
    • Polo-mint sign (partial filling defect surrounded by contrast)
✔ (Low grade) ✔ (In case of massive PE) - - - -
Congestive heart failure
  • Goldberg's criteria may aid in diagnosis of left ventricular dysfunction: (High specificity)
    • SV1 or SV2 + RV5 or RV6 ≥3.5 mV
    • Total QRS amplitude in each of the limb leads ≤0.8 mV
    • R/S ratio <1 in lead V4
- - - - - -
Percarditis
  • ST elevation
  • PR depression
  • Large collection of fluid inside the pericardial sac (pericardial effusion)
  • Calcification of pericardial sac
✔ (Low grade) ✔ (Relieved by sitting up and leaning forward) - - - - -
  • May be clinically classified into:
    • Acute (< 6 weeks)
    • Sub-acute (6 weeks - 6 months)
    • Chronic (> 6 months)
Pneumonia - - - -
Vasculitis

Homogeneous, circumferential vessel wall swelling

-
Chronic obstructive pulmonary disease (COPD)
  • On CT scan:
  • On MRI:
    • Increased diameter of pulmonary arteries
    • Peripheral pulmonary vasculature attentuation
    • Loss of retrosternal airspace due to right ventricular enlargement
    • Hyperpolarized Helium MRI may show progressively poor ventilation and destruction of lung
- - - - - -

References

  1. Bell MM (2015). "Lipoid pneumonia: An unusual and preventable illness in elderly patients". Can Fam Physician. 61 (9): 775–7. PMC 4569110. PMID 26371101.
  2. Parameswaran, K.; Anvari, M.; Efthimiadis, A.; Kamada, D.; Hargreave, F.e; Allen, C.j (2000). "Lipid-laden macrophages in induced sputum are a marker of oropharyngeal reflux and possible gastric aspiration". European Respiratory Journal. 16 (6): 1119–1122. doi:10.1034/j.1399-3003.2000.16f17.x. ISSN 0903-1936.

Template:WH Template:WS